Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.

1 February 1998

journal article
clinical trial
Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology

Vol. 16 (2) , 593-602
https://doi.org/10.1200/jco.1998.16.2.593

Abstract

PURPOSETo determine the efficacy and safety of 21 monthly cycles of pamidronate therapy in patients with advanced multiple myeloma.PATIENTS AND METHODSPatients with stage III myeloma and at least o...

Keywords

SAFETY
MULTIPLE MYELOMA
SURVIVAL
EFFICACY
PAMIDRONATE
MONTHLY
TOLERATED
SKELETAL EVENTS